October 9, 2015 — Cardinal Health is launching its expanded portfolio in the cardiovascular space including the latest ...
Oregon Health & Science University (OHSU) now offers patients one of the most advanced computed tomography (CT) imaging systems available with the installation of Toshiba’s Aquilion ONE ViSION Edition. OHSU, a nationally prominent research university and Oregon’s only public academic medical center, acquired the new system to help improve its diagnostic capabilities for trauma, cardiac, stroke and pediatric patients. Adding the first 640-slice system in the state of Oregon allows OHSU to deliver better patient care and maintain its position as one of the leading health care institutions in the United States.

Cardiovascular information systems (CVIS or cardiac PACS) have undergone a transformation over the past few years to ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Shimadzu Medical Systems USA announced the availability of the MIX package for the Trinias Cardiovascular suites. Based on the three main operating concepts (SCORE Imaging, SMART Design and SMILE Concept) for Trinias, Shimadzu is providing new features for taking minimally invasive procedures to new levels.
Personal MedSystems introduced the first and only 22-lead mobile electrocardiogram (ECG) system, CardioSecur, at the European Society of Cardiology Congress 2015, Aug. 29-Sept. 2 in London.
Invitae Corp., a genetic information company, announced the expansion of its cardiology offering, including more than 30 cardiovascular test panels for arrhythmias, cardiomyopathies, aortopathies, familial hypercholesterolemia, pulmonary hypertension and congenital heart disease.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

The Centers for Medicare and Medicaid Services (CMS) released the final version of Stage 3 Meaningful Use (MU) requirements related to healthcare information technology (IT) Oct. 6. CMS will take public comment on the new rules for 60 days beginning Oct. 16.

The results of a research study indicate that interventional cardiologists receive “very high” radiation exposure levels to the left side of the head specifically when performing fluoroscopically guided invasive cardiovascular (CV) procedures. Even with modern imaging equipment and shielding, a significant exposure difference was seen between the two sides of the head.
Acutus Medical, a global heart rhythm technology company, presented data that show the AcQMap High Resolution Imaging and Mapping System more rapidly and clearly maps atrial fibrillation (AF) than segmented computed tomography (sCT) mapping, the current standard for most AF ablation procedures. The initial study findings were presented during an oral presentation at the 10th annual Heart Rhythm Congress held in Birmingham, United Kingdom, Oct. 4-7, 2015.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The novel Aortix device has earned a spot among the diagnostic and therapeutic modalities accepted for presentation in the Interventional Innovation “Shark Tank” Competition at the Transcatheter Cardiovascular Therapeutics (TCT) annual scientific symposium. The event will be held Tuesday, Oct. 13, in San Francisco, California.
GE Healthcare announced the creation of a new business unit, Sustainable Healthcare Solutions (SHS), that will develop high-value, low-cost technologies and healthcare delivery solutions across multiple care settings. The new organization will invest $300 million as part of a multi-phase effort to develop a more robust affordable healthcare portfolio for customers. The unit will combine GE Healthcare’s operations in India, South Asia, Africa and Southeast Asia.
Beaumont Hospital - Royal Oak is the first in Michigan and one of just a handful in the United States to offer fractional flow reserve by computed tomography, also known as FFR-CT. The technology is a noninvasive, diagnostic tool recently approved by the U.S. Food and Drug Administration (FDA) and developed by HeartFlow Inc.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Procyrion Inc. of Houston has been awarded the grand prize of $20,000 in the 2015 "Create the Future" Design Contest for the first catheter-deployed heart pump intended for long-term treatment of chronic heart failure.
October 5, 2015 — The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s Synergy Bioabsorbable ...
Cyberonics Inc. announced results from the extension of the ANTHEM-HF clinical study (ENCORE Study). Results of the study presented by a prominent heart failure (HF) specialist during a major cardiology congress in the United States show that autonomic regulation therapy (ART) in patients with moderate to severe chronic HF and impaired heart function is well-tolerated, safe, improves the heart's ability to pump blood, and reduces the frequency and severity of symptoms associated with chronic HF.